3/28/14 Contest update
Biotechs had a lousy week and Contest portfolios did not escape the drubbing. Was it, as @RNAiAnalyst tweeted, temporary “GILD by association” or something more chronic? Time will tell.
Despite the week’s flogging, the Contest median still closed Friday up a respectable 20.21% YTD (vs. up 31.63% YTD a week ago). Meanwhile, the Nasdaq Biotech Index finished the week up a mere 1.13% YTD (vs. up 8.76% YTD a week ago) and the Nasdaq Composite Index was now down -.50% YTD (vs. up 2.40% YTD a week ago).
JB118's portfolio, up 63.21% YTD, reclaimed first place, while GUERL’s portfolio, up 61.57% YTD, held second place. Hit hard by TKMR’s plunge, GENE’s portfolio, up 59.41% YTD, dropped to third place.
At Friday's close, 6 Contest portfolios had fallen to the red but an impressive 40 of the 46 were beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
Portfolio adjustments: none
(All corrections, especially adjustments for splits, greatly appreciated.)
Have a safe & fun weekend biotechies!
Peace & good health,
Bulba
3/28/14
Rank Name Profit/Loss
1 JB118 63,208
2 GUERL 61,568
3 GENE 59,413
4 BIOMAV 44,857
5 CLARK 41,874
6 MCBIO 40,109
7 ROBERT 36,564
8 NIGEL 33,896
9 RRGE 31,933
10 BTH2013 31,557
Week's Top 5 Gainers
Symbol 3/21 3/28 Wk.%chg.
AMF.TO 0.36 0.41 15.49%
MEIP 10.08 11.54 14.48%
SSS.V 0.48 0.54 12.50%
KERX 14.84 16.61 11.93%
CYTN.SW 2.72 2.98 9.56%
Week's Worst 5 Losers
Symbol 3/21 3/28 Wk.%chg.
EXEL 6.29 3.380 -46.26%
ECX.DE 8.20 5.180 -36.83%
CAPR 10.50 7.700 -26.67%
KPTI 42.07 30.960 -26.41%
TKMR 25.91 19.495 -24.76% |
